Sygnis SA (WSE:SYG)
 2.480
 +0.080 (3.33%)
  At close: Oct 31, 2025
Sygnis Revenue
Sygnis had revenue of 3.39M PLN in the quarter ending June 30, 2025, with 22.87% growth. This brings the company's revenue in the last twelve months to 15.41M, down -8.19% year-over-year. In the year 2023, Sygnis had annual revenue of 20.03M, down -29.73%.
Revenue (ttm) 
 15.41M
Revenue Growth 
 -8.19%
P/S Ratio 
 4.34
Revenue / Employee 
 856.22K
Employees 
 46
Market Cap 
66.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2023 | 20.03M | -8.48M | -29.73% | 
| Dec 31, 2022 | 28.51M | 25.11M | 739.70% | 
| Dec 31, 2021 | 3.39M | 600.08K | 21.47% | 
| Dec 31, 2020 | 2.79M | 509.95K | 22.32% | 
| Dec 31, 2019 | 2.28M | -236.14K | -9.37% | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| NEUCA | 13.04B | 
| Diagnostyka | 2.17B | 
| Centrum Medyczne ENEL-MED | 789.78M | 
| Synektik Spólka Akcyjna | 623.20M | 
| Mercator Medical | 579.83M | 
| Voxel | 560.38M | 
| Selvita | 373.90M | 
| Celon Pharma | 206.22M |